Clinuvel Pharmaceuticals
CUV.AX
#6929
Rank
NZ$0.73 B
Marketcap
$14.63
Share price
-1.79%
Change (1 day)
-18.92%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: NZ$51.47 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$51.84 Million. In 2023 the company made an earning of NZ$51.47 Million, an increase over its 2022 earnings that were of NZ$40.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023NZ$51.47 M27.77%
2022NZ$40.28 M22.23%
2021NZ$32.96 M114.01%
2020NZ$15.4 M-29.03%
2019NZ$21.7 M32.76%
2018NZ$16.34 M75.24%
2017NZ$9.32 M-332.09%
2016-NZ$4.02 Million-70.52%
2015-NZ$13.64 Million53.56%
2014-NZ$8.88 Million-16.31%
2013-NZ$10.61 Million-37.85%
2012-NZ$17.07 Million-18%
2011-NZ$20.82 Million25.86%
2010-NZ$16.54 Million-21.79%
2009-NZ$21.15 Million-11.73%
2008-NZ$23.96 Million80.71%
2007-NZ$13.26 Million-2.86%
2006-NZ$13.65 Million-4.95%
2005-NZ$14.36 Million60.55%
2004-NZ$8.95 Million97.37%
2003-NZ$4.54 Million50.62%
2002-NZ$3.01 Million121.22%
2001-NZ$1.36 Million254.48%
2000-NZ$0.39 Million